Keyword

C225

Description: A chimeric monoclonal antibody, also called cetuximab, that targets the epidermal growth factor receptor and is studied in cancer treatment.
Wikidata ID: wiki/Q420296
OpenAlex ID: keywords/c225
2006 · John C. Sok, Francesca M. Coppelli, et al. · Clinical Cancer Research · 536
2001 · K.J. Busam, P. Capodieci, et al. · British Journal of Dermatology · 430
2001 · J Mendelsohn · Endocrine Related Cancer · 352
2005 · Klaus Dittmann, Claus Mayer, et al. · Radiotherapy and Oncology · 316
1996 · Marie Prewett, Howard I. Scher, et al. · Journal of Immunotherapy · 266
1997 · Jennifer A Harding, Charles M Engbers, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 222
2001 · Paul M Harari, Shyh-Min Huang · International Journal of Radiation Oncology*Biology*Physics · 220
2017 · Li Ma, Peng Sun, et al. · International Journal of Molecular Medicine · 212
2004 · Luka Milas, Zhen Fan, et al. · International Journal of Radiation Oncology*Biology*Physics · 177
2003 · Robert J. Motzer, Robert Amato, et al. · Investigational New Drugs · 164
1999 · Mansoor N. Saleh, Kevin P. Raisch, et al. · Cancer Biotherapy and Radiopharmaceuticals · 164
2001 · William J. Slichenmyer, David W. Fry · Seminars in Oncology · 158
Works count: 132
Citation count: 10,530
Year
Topic
Type